Cathflo Activase
Active substance: alteplase
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ALTEPLASE 2.2 mg/2mL
United StatesActive
Marketing holder: Genentech, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ALTEPLASE · 2.2 mg/2mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-cb36-7386-865c-38d96c60d914,01a12093-93ac-7507-816a-34785c4febb2,01a12096-00a4-72a2-b24e-b2ed66484efc;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50242-041
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 50242-041 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50242-041 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50242-041 · Verified 2026-10-09 · open in source